Whether and how human tumours are genetically unstable has been debated for
decades. There is now evidence that most cancers may indeed be genetically
unstable, but that the instability exists at two distinct levels. In a sma
ll subset of tumours, the instability is observed at the nucleotide level a
nd results in base substitutions or deletions or insertions of a few nucleo
tides. in most other cancers, the instability is observed at the chromosome
level, resulting in losses and gains of whole chromosomes or large portion
s thereof. Recognition and comparison of these instabilities are leading to
new insights into tumour pathogenesis.